Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae.

× No keyword cloud information.

11 in total

1. Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors: R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal: Infect Immun Date: 2001-06 Impact factor: 3.441

2. Interaction of pneumococcal histidine triad proteins with human complement.

Authors: Merit Melin; Emmanuel Di Paolo; Leena Tikkanen; Hanna Jarva; Cecile Neyt; Helena Käyhty; Seppo Meri; Jan Poolman; Merja Väkeväinen
Journal: Infect Immun Date: 2010-03-01 Impact factor: 3.441

3. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.

Authors: Y Zhang; A W Masi; V Barniak; K Mountzouros; M K Hostetter; B A Green
Journal: Infect Immun Date: 2001-06 Impact factor: 3.441

4. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.

Authors: Fabrice Godfroid; Philippe Hermand; Vincent Verlant; Philippe Denoël; Jan T Poolman
Journal: Infect Immun Date: 2010-10-18 Impact factor: 3.441

5. Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytes.

Authors: P A Majcherczyk; E Rubli; D Heumann; M P Glauser; P Moreillon
Journal: Infect Immun Date: 2003-07 Impact factor: 3.441

6. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.

Authors: Haijun Tian; Sarah Weber; Peter Thorkildson; Thomas R Kozel; Liise-Anne Pirofski
Journal: Infect Immun Date: 2009-01-21 Impact factor: 3.441

Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae.

1. Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

2. Interaction of pneumococcal histidine triad proteins with human complement.

3. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.

4. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.

5. Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytes.

6. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.

7. Anatomical site-specific contributions of pneumococcal virulence determinants.

Review 8. Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.

9. Pathogenicity and virulence of Streptococcus pneumoniae: Cutting to the chase on proteases.

10. Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.